Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.45 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | GLS | O94925 | 4/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13946506 | 1.00 | MAPT (0.55) | MAPTKMT2AHTTSCN5ASCN9A | |
| SCHEMBL13946510 | 1.00 | MAPT (0.55) | MAPTKMT2AHTTSCN5ASCN9A | |
| Benzoic Acid SCHEMBL30973625 | 0.91 | TSHR (0.48) | MAPTKMT2AHTTSCN5ASCN9A | |
| Piperazine SCHEMBL10694183 | 0.89 | KMT2A (0.46) | MAPTKMT2AHTTSCN5ASCN9A | |
| SCHEMBL19205720 | 0.84 | SCN5A (0.54) | MAPTKMT2AHTTSCN5ASCN9A | |
| SCHEMBL584028 | 0.83 | CYP2C19 (0.47) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL7899580 | 0.83 | CYP2C19 (0.47) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL5570579 | 0.83 | CYP2C19 (0.47) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL8360666 | 0.82 | SCN5A (0.49) | MAPTKMT2ASCN5ASCN9AHIF1A | |
| SCHEMBL5898532 | 0.82 | CES2 (0.44) | KMT2ASCN5ASCN9ACYP2C19KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4525820-A1 | ANTICAKING COMPOSITION AND METHOD FOR IMPROVING FLOWING PROPERTIES OF HYGROSCOPIC TIN SALTS | HONEYWELL INTERNATIONAL INC. (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-114245016-B | Control method and system for video shooting, computer equipment and storage medium | 睿魔智能科技（深圳）有限公司 | 2024-10-18 | — | — | CN | disclosed |
| WO-2024015247-A1 | ANTICAKING COMPOSITION AND METHOD FOR IMPROVING FLOWING PROPERTIES OF HYGROSCOPIC TIN SALTS | HONEYWELL INTERNATIONAL INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20240009094-A1 | ANTICAKING COMPOSITION AND METHOD FOR IMPROVING FLOWING PROPERTIES OF HYGROSCOPIC TIN SALTS | HONEYWELL INTERNATIONAL INC. (US) | 2024-01-11 | — | — | US | disclosed |
| CN-117003665-A | Synthesis process of N, N-diethyl-2-hydroxy-2-phenylacetamide | 百新(北京)药业科技有限责任公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-110791509-B | Pediococcus acidilactici optimized expression sequence, expression vector, preparation method and strain thereof | 深圳市圣西马生物技术有限公司 | 2023-09-08 | — | — | CN | disclosed |
| US-8350076-B2 | Sodium channel blockers | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2013-01-08 | — | — | US | disclosed |
| EP-2097385-A1 | 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS | Merck & Co., Inc. (US) | 2009-09-09 | — | — | EP | disclosed |
| CN-101511840-A | Phosphoinositide 3-kinase inhibitor compounds and methods of use thereof | GENENTECH INC (US) | 2009-08-19 | — | — | CN | disclosed |
| US-20090030056-A1 | NOVEL SODIUM CHANNEL BLOCKERS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2009-01-29 | — | — | US | disclosed |
| US-7439383-B2 | Sodium channel blockers | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-10-21 | — | — | US | disclosed |
| US-7414078-B2 | Oral general anesthetics and metabolitically resistant anticonvulsants | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-08-19 | — | — | US | disclosed |
| WO-2008051532-A1 | 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS | MERCK & CO., INC. (US) | 2008-05-02 | — | — | WO | disclosed |
| US-20060287397-A1 | Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity | MEZA TOLEDO SERGIO E | 2006-12-21 | — | — | US | disclosed |
| WO-1997023202-A1 | SUBTYPE-SELECTIVE NMDA RECEPTOR LIGANDS AND THE USE THEREOF | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITYA ND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1997-07-03 | — | — | WO | disclosed |
| US-5463125-A | 3-hydroxy-3-phenylpentamide | SANDOVAL GUILLERMO C (MX) | 1995-10-31 | — | — | US | disclosed |
| US-5463125-A | 3-hydroxy-3-phenylpentamide | SANDOVAL GUILLERMO C (MX) | 1995-10-31 | — | — | US | disclosed |
| US-4889853-A | CEREBRAL INSUFFICIENCY; NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS; ANTIHYPOXIA AGENTS | SUNTORY LIMITED (JP) | 1989-12-26 | — | — | US | disclosed |
| EP-0298758-A2 | Hydroquinonylphenyl butyric acid amide derivative | SUNTORY LIMITED (JP) | 1989-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287397-A1 | Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity | GABRB2, HRH3, HRH4 | MAPT 2331/4885KMT2A 211/4885HTT 595/4885 |
| US-20090030056-A1 | NOVEL SODIUM CHANNEL BLOCKERS | SCNN1B, SCN1B, KCNN2 | MAPT 2919/4885KMT2A 3061/4885HTT 3895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.